Search:

Pharmaceuticals Headlines from PR Newswire


< Go Back

Xencor to Host Second Quarter 2014 Financial Results Webcast and Conference Call
Celsion Announces Positive Interim Data Update from its Phase 2 DIGNITY Study in Breast Cancer
Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea
Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements
Abbott Introduces New Similac® Breastfeeding Supplement with DHA, Lutein and Vitamin E
Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium
Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40.
Lilly Reports Second-Quarter 2014 Results
OncoGenex to Report Financial Results for Second Quarter 2014 on August 7, 2014
TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform
The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF)
Pfenex Inc. Announces Pricing Of Initial Public Offering
The Leukemia & Lymphoma Society Applauds FDA's Approval of Idelalisib To Treat Three Types of Blood Cancers
Benefits and Safety of Pradaxa® (dabigatran etexilate mesylate) Repeatedly Confirmed
SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today.
AbbVie to Host Second-Quarter Earnings Conference Call
Pharmavite Appoints Timothy Toll Chief Customer Officer
Announcing a New Regional Approach to Medicare Quality Improvement
New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry
Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial
Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects English
Mevesi Enhances Solutions with Variable Print Media Capabilities!
Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call
Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse
Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference
Women Taking Too Much Calcium Create Health Risk
Diabacor™ Discusses the High Value of Fiber for the Diabetic
ACON Investments Acquires Injured Workers Pharmacy
Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis English
Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado
MiMedx Files Its Initial Investigational New Drug Application
GSK CEO and CFO Interviewed on Q2 2014 Results and Strategy Update
Mylan Wins Motion for Temporary Restraining Order Against Apotex for Authorized Generic of Paxil® CR
Pelvalon Announces Results from the LIFE Pivotal Trial at the 2014 AUGS/IUGA Conference
ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome
Emulsifiers - Global Strategic Business Report: Updated 2014 Report
Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu
Essentialis Secures Foundation for Prader-Willi Research Grant to Help Advance DCCR in the Treatment of Prader-Willi Syndrome
Occlutech Wins Invalidation of St Jude Patent
Taiho Pharmaceutical Invests US$30 Million in Remiges BioPharma Fund, LP
Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR)
Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 English
Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014
Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018
New Study: H.R. 4577 to Cost $21 Billion over 10 Years
Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research
Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted

< Prev Next >
PR Newswire - United Business Media